Binding properties of a potent, long-acting new thromboxane receptor antagonist, [3H]S 18886, on human, rat and dog platelet membrane

被引：0
|
作者：
Descombes, JJ [1 ]
Menant, Y [1 ]
Lavielle, G [1 ]
Verbeuren, TJ [1 ]
机构：
[1] Inst Rech Servier, Div Angiol, F-92150 Suresnes, France
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1997年 / 122卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
381P
引用
收藏
页码：U112 / U112
页数：1
相关论文
共 18 条
  • [1] RECEPTOR-BINDING PROPERTIES INVITRO AND INVIVO OF RITANSERIN - A VERY POTENT AND LONG-ACTING SEROTONIN-S-2 ANTAGONIST
    LEYSEN, JE
    GOMMEREN, W
    VANGOMPEL, P
    WYNANTS, J
    JANSSEN, PFM
    LADURON, PM
    MOLECULAR PHARMACOLOGY, 1985, 27 (06) : 600 - 611
  • [2] BINDING CHARACTERISTICS OF THE NEW THROMBOXANE A2 PROSTAGLANDIN H-2-RECEPTOR ANTAGONIST [3H]BAY U-3405 TO WASHED HUMAN PLATELETS AND PLATELET MEMBRANES
    THEIS, JGW
    DELLWEG, H
    PERZBORN, E
    GROSS, R
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) : 495 - 503
  • [3] Binding characteristics of a potent AMPA receptor antagonist [3H]Ro 48-8587 in rat brain
    Mutel, V
    Trube, G
    Klingelschmidt, A
    Messer, J
    Bleuel, Z
    Humbel, U
    Clifford, MM
    Ellis, GJ
    Richards, JG
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (01) : 418 - 426
  • [4] Distinct binding properties of the AT1 receptor antagonist [3H]candesartan to intact cells and membrane preparations
    Fierens, FLP
    Vanderheyden, PML
    Roggeman, C
    Vande Gucht, P
    De Backer, JP
    Vauquelin, G
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (07) : 1273 - 1279
  • [5] Antithrombotic properties of the thromboxane A2/prostaglandin H2 receptor antagonist S18886 on prevention of platelet-dependent cyclic flow reductions in dogs
    Maalej, N
    Osman, HE
    Shanmuganayagam, D
    Shebuski, RJ
    Folts, JD
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 45 (05) : 389 - 395
  • [6] Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain
    Betancur, C
    Canton, M
    Burgos, A
    Labeeuw, B
    Gully, D
    Rostène, W
    Pélaprat, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 343 (01) : 67 - 77
  • [7] BRL-46470A - A HIGHLY POTENT, SELECTIVE AND LONG-ACTING 5-HT(3) RECEPTOR ANTAGONIST WITH ANXIOLYTIC-LIKE PROPERTIES
    BLACKBURN, TP
    BAXTER, GS
    KENNETT, GA
    KING, FD
    PIPER, DC
    SANGER, GJ
    THOMAS, DR
    UPTON, N
    WOOD, MD
    PSYCHOPHARMACOLOGY, 1993, 110 (03) : 257 - 264
  • [8] FAMOTIDINE, A NEW, POTENT, LONG-ACTING HISTAMINE H2-RECEPTOR ANTAGONIST - COMPARISON WITH CIMETIDINE AND RANITIDINE IN THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME
    HOWARD, JM
    CHREMOS, AN
    COLLEN, MJ
    MCARTHUR, KE
    CHERNER, JA
    MATON, PN
    CIARLEGLIO, CA
    CORNELIUS, MJ
    GARDNER, JD
    JENSEN, RT
    GASTROENTEROLOGY, 1985, 88 (04) : 1026 - 1033
  • [9] Distribution and abundance of binding sites for a potent, selective AMPA receptor antagonist [3H]Ro 48-8587 in human brain
    Richards, JG
    Messer, J
    Bleuel, Z
    Malherbe, P
    Klingelschmidt, A
    Faull, RLM
    Mutel, V
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U12 - U12
  • [10] EFFECT OF BMY-25368, A POTENT AND LONG-ACTING HISTAMINE H2-RECEPTOR ANTAGONIST, ON GASTRIC-SECRETION AND ASPIRIN-INDUCED GASTRIC-LESIONS IN THE DOG
    CAVANAGH, RL
    BUYNISKI, JP
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1989, 3 (03) : 299 - 313
12